Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up

M F M Gielissen, C A H H V M Verhagen, G Bleijenberg, M F M Gielissen, C A H H V M Verhagen, G Bleijenberg

Abstract

An earlier randomised-controlled trial demonstrated the positive effects of cognitive behaviour therapy (CBT), especially designed for fatigued cancer survivors in reducing fatigue, functional impairments and psychological distress. In the current prospective study, we were able to examine the long-term effect of CBT in patients who completed the therapy. Predictors of fatigue severity at follow-up were exploratory investigated. Sixty-eight patients who completed CBT were assessed at pretreatment, post-treatment and at follow-up (mean follow-up 1.9 years (s.d. 1.0), range: 1-4 years). To analyse possible predictors of treatment outcome a linear regression (enter) was carried out. Improvements on fatigue severity, functional impairment and psychological distress after CBT appeared to remain stable during a follow-up period. Patients who were not fatigued anymore at follow-up were not different from a reference group of non-fatigued cancer survivors. The explorative regression analysis showed that fatigue severity, psychological distress and somatic attributions at pretreatment contributed to persistent fatigue severity at follow-up. Cognitive behaviour therapy, especially designed for post-cancer fatigue, is successful in reducing fatigue and functional impairment in cancer survivors. Moreover, these positive effects were maintained at about 2 years after finishing CBT.

Figures

Figure 1
Figure 1
Trial profile.

References

    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull M, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razav D, Rofe P, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376
    1. Arindell WA, Ettema JHM (1986) SCL-90, Handleiding Bij Een Multidimensionele Psychopathologie-Indicator. Swets & Zwitlinger B.V: Amsterdam
    1. Basen-Engquist K, Carmack Taylor CL, Rosenblum C, Smith MA, Shinn EH, Greisinger A, Gregg X, Massey P, Valero V, Rivera E (2006) Randomized pilot test of lifestyle physical activity intervention for breast cancer survivors. Patient Educ Couns 64: 225–234
    1. Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The sickness impact profile. Development and final revision of a health status measure. Med Care 19: 787–805
    1. Beurskens AJHM, Bultman U, Kant IJ, Vercoulen JHMM, Bleijenberg G, Swaen GMH (2000) Fatigue among working people: validity of a questionnaire measure. Occup Environ Med 57: 353–357
    1. Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR (2006) Fatigue in long-term breast carcinoma survivors. A longitudinal investigation. Cancer 106: 751–758
    1. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16: 1689–1696
    1. Brom D, Kleber RJ (1985) De Schok Verwerkings Lijst [the Impact of Event Scale – Dutch adaptation]. Ned Tijdschr Psych 40: 164–168
    1. Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS (2003) Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 21: 1660–1668
    1. Creamer M, Bell R, Failla S (2003) Psychometric properties of the impact of event scale – revised. Behav Res Ther 41: 1489–1496
    1. Culos-Reed SN, Carlson LE, Daroux LM, Hately-Aldous S (2006) A pilot study of yoga for breast cancer survivors: physical and psychological benefits. Psycho–Oncol 15: 891–897
    1. Derogatis LR (1994) SCL-90-R: Administration, Scoring and Procedures Manual. 3rdedn.. National Computer Systems: MN, USA
    1. Dittner AJ, Wessley SC, Brown RG (2004) The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 56: 157–170
    1. Gielissen MFM, Schattenberg AVM, Verhagen CAHHVM, Rinkes MJ, Bremmers MEJ, Bleijenberg G (2007) Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transpl 39: 595–603
    1. Gielissen MFM, Verhagen S, Witjes AJ, Bleijenberg G (2006) The effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared to patients waiting for this treatment. A randomized controlled trial. J Clin Oncol 24: 4882–4887
    1. Hjermstad SD, Fosså SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH (2005) Fatigue in long-term Hodgkin's disease survivors: A follow-up study. J Clin Oncol 23: 6587–6595
    1. Jacobs HM, Luttik A, Touw-Otten FW, de Melker RA (1990) [the sickness impact profile; results of an evaluation study of the Dutch version] De ‘sickness impact profile’; resultaten van een valideringsonderzoek van de Nederlandse Versie. Ned Tijdschr Geneeskd 134: 1950–1954
    1. Molassiotis A, Sylt P, Diggins H (in press) The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med
    1. Ng AK, Li S, Recklitis C, Neuberg D, Chakrabartis S, Silver B, Diller L (2005) A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 16: 1949–1955
    1. Pinto BM, Frierson GM, Rabin C, Trunzo JJ, Marcus BH (2005) Home-based physical activity intervention for breast cancer patients. J Clin Oncol 23: 3577–3587
    1. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo ThM, Severens JL, van der Wilt G, Spinhoven P, van der Meer JWM (2001) Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomised controlled trial. Lancet 357: 841–847
    1. Prue G, Rankin J, Allen J, Gracey J, Cramp F (2006) Cancer related fatigue: a critical appraisal. Eur J Cancer 42: 846–863
    1. Servaes P, Verhagen C, Bleijenberg G (2002a) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38: 27–43
    1. Servaes P, Prins J, Verhagen S, Bleijenberg G (2002b) Fatigue after breast cancer and in chronic fatigue syndrome: similarities and differences. J Psychosom Res 52: 453–459
    1. Servaes P, Verhagen C, Bleijenberg G (2002c) Determinants of chronic fatigue in disease-free breast cancer patients, a cross-sectional study. Ann Oncol 13: 589–598
    1. Servaes P, Verhagen C, Bleijenberg G (in press) the course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psycho–Oncol
    1. Servaes P, Verhagen C, Schreuder BHW, Veth RPH, Bleijenberg G (2003) Fatigue after treatment for malignant and benign bone and soft tissue tumors. J Pain Symptom Manag 26: 1113–1122
    1. Stulemeijer M, de Jong LWAM, Fiselier TJW, Hoogveld SWB, Bleijenberg G (2005) Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. Br Med J 330: 7481–7486
    1. Sugawara Y, Akechi T, Okuyama T, Matsuoka Y, Nakano T, Inagati M, Imoto S, Fujimori M, Hosaka T, Uchitomi Y (2005) Occurrence of fatigue and associated factors in disease-free breast cancer patients without depression. Support Care Cancer 13: 628–636
    1. Van der Ploeg E, Mooren TTM, Kleber RJ, van der Velden PG, Brom D (2004) Construct validation of the dutch version of the impact of event scale. Psych Assess 16: 16–26
    1. van Sonderen E (1993) Sociale Steun Lijst – Interacties (SSL-I) en Sociale Steun Lijst – Discrepanties (SSL-D). Noordelijk Centrum voor Gezondheidsvraagstukken: Groningen
    1. Vercoulen JH, Swanink CM, Galama JM, Fennis JFM, Jongen PJH, Hommes OR, van der Meer JW, Bleijenberg G (1998) The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 45: 507–517
    1. Vercoulen JHHM, Swanink CMA, Fennis JFM, Galama JMD, van der Meer JWM, Bleijenberg G (1994) Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38: 383–392
    1. Young KE, White CA (2006) The prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res 60: 29–38

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe